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GRAFTED CROSS-LINKED POLYOLEFIN 
SUBSTRATES FOR PEPTIDE SYNTHESIS 
AND ASSAYS 
FIELD OF THE INVENTION 
The present invention concerns a solid support for the 
solid-phase synthesis of, in particular, peptides or proteins in 
high yield and in high purity. The support is Well suited both 
to the synthesis of a single peptide or protein and to the 
parallel and substantially simultaneous synthesis of a plu 
rality thereof. More speci?cally, the invention relates to a 
solid support based on a cross-linked polyole?n substrate, 
especially a cross-linked polyethylene substrate, to Which 
are grafted polymer chains such as polystyrene chains, the 
polymer chains being functionaliZed With a chemical func 
tionality facilitating the formation of an anchoring linkage 
betWeen the polymer moiety and another chemical species, 
the polymer chains such as polystyrene chains optionally 
further bearing substituents Which are not reactive under the 
conditions prevailing in the synthesis. 
Syntheses employing the substrate of the invention can 
make use of established chemical methodology, and the 
substrate is Well suited to syntheses on an analytical 
(microgram) scale or on a preparative (milligram or larger) 
scale. Furthermore, the substrate of the invention can be 
employed in both batchWise and continuous-?oW proce 
dures Which are performed manually, semi-automatically or 
fully automatically. 
In addition, the solid supports of the invention are par 
ticularly Well suited for use in solid-phase biosystems, 
notably bioassays, such as immunoassays, DNA hybridiZa 
tion assays or PCR ampli?cation. 
BACKGROUND OF THE INVENTION 
Until quite recently, solid-phase methods for the synthesis 
of peptides or proteins have to a large eXtent been based on 
the original methodology developed by Merri?eld, employ 
ing a functionaliZed cross-linked styrene/divinylbenZene 
copolymer, the cross-linked copolymer having been formed 
by the polymeriZation of styrene monomer to Which has 
been added a feW per cent (typically about 2%) of divinyl 
benZene. This copolymer is generally provided in the form 
of beads or particles, often With a dominant particle siZe of 
20—80 pm. The functionaliZation originally preferred by 
Merri?eld [see eg J. Am. Chem. Soc. 85, 2149 (1963)] Was 
a functionaliZation of the aromatic rings of the copolymer 
With chloromethyl groups, introduced via reaction of the 
solid copolymer With SnCl4/chloromethyl methyl ether, 
although a number of other functionalities, including 
aminomethyl, ot-aminobenZyl and ot-amino-4 
methylbenZyl, have subsequently been employed. Regard 
less of its nature, the purpose of the functionality is normally 
to form an anchoring linkage betWeen the copolymer solid 
support and the C-terminal of the ?rst amino acid Which it 
is desired to couple to the solid support. Later re?nements of 
the Merri?eld methodology have included the further 
introduction, betWeen a functionality (eg one of the above 
mentioned functionalities) on the polystyrene chains and the 
C-terminal of the ?rst amino acid Which is to be coupled, of 
a bifunctional “spacer” or “handle” group Whose reactivity 
is tailored inter alia to meet desired requirements With 
respect both to the coupling of the ?rst amino acid to the 
solid support and/or to the ease With Which the completed, 
synthesiZed peptide or protein chain is cleaved from the 
solid support. Examples of such spacer groups include the 
phenylacetamidomethyl (Pam) and the p-alkoXybenZyl ester 
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2 
systems. Barany et al. [Int. J. Peptide Protein Res. 30, 
705—739 (1987)] have revieWed the development of solid 
phase peptide synthesis methodology from its introduction 
by Merri?eld up to about 1986. 
The advances in biotechnology Which have been made in 
the last decade or so, particularly in the area of recombinant 
DNA, have produced a situation in Which vast numbers of 
neW protein sequences With unde?ned or unknoWn function 
and/or unknoWn biological activity have become available. 
In this connection, detailed structural analysis by site 
directed mutagenesis or similar molecular engineering tech 
niques has provided a useful approach to the study of the 
roles of amino acid residues in active sites of proteins. 
HoWever, speci?c information concerning biologically 
active functional subunits (peptides) containing ca. 5—40 
amino acid residues is preferably obtained through chemical 
synthesis. Whilst the chemical methodology Which had been 
developed Within the period revieWed by Barany (vide 
supra) Was quite capable of yielding such peptides reliably 
and in high purity When using the above-outlined “conven 
tional” method of solid-phase peptide synthesis (via a “lin 
ear” mode of approach), only one peptide Was produced per 
synthesis. 
A greater need than ever thus arose for methods employ 
ing a “simultaneous” or “parallel” mode of approach to the 
synthesis of peptides so that a large number of peptides 
could be synthesiZed simultaneously (or substantially 
simultaneously). These peptides could then be used, for 
example, to de?ne and map the functional entities of pro 
teins. The obvious advantages of a method permitting the 
parallel and substantially simultaneous synthesis of a mul 
titude of peptides are the attendant saving in time, and the 
redundancy of the repetitive labour involved in accomplish 
ing the synthesis of each peptide individually. 
In this connection, a basic feature of the solid-phase 
technique of peptide synthesis is that in each elongation of 
the peptide chain With a further amino acid, all treatment 
steps are repetitive of the previous cycle With the possible 
eXception of the amino acid coupling step itself, in Which a 
further amino acid that may or may not be identical With that 
coupled in the preceding cycle is coupled to the peptide 
chain. Thus, parallel, substantially simultaneous synthesis of 
tWo or more peptides could be achieved by performing in 
parallel the repetitive steps, such as deprotection, 
neutraliZation, and Washing, Which are common to the 
parallel syntheses. The major technical dif?culty here had 
been the attainment of compartmentaliZation of each amino 
acid coupling step so that cross-contamination did not occur. 
Several different methods have been proposed for the 
substantially simultaneous synthesis of a number of pep 
tides: 
One of these methods [Geysen et al., Proc. Natl. Acad. 
Sci. USA. 81, 3998—4002 (1984) and 82, 178—82 (1985)] 
Was devised for rapid screening of peptide epitopes via 
ELISA (EnZyme Linked Immunosorbent Assay) in 
96-microtiter Wells. It utiliZes acrylic acid-grafted polyeth 
ylene rod-and-96-microtiter Wells to immobiliZe groWing 
peptide chains and to perform the compartmentaliZed syn 
thesis. HoWever, While highly effective, the method is not 
applicable on a preparative scale, i.e. to the preparation of 
milligram quantities. 
Asecond method [Houghten, Proc. Natl. Acad. Sci. USA. 
82, 5131—35 (1985)] utiliZes a “tea bag” containing the 
traditionally used polymer beads to compartmentaliZe the 
synthesis, portions of peptidyl-resin beads being kept apart 
in sealed bags of ?ne-mesh polypropylene net. The latter 
method is relevant to the preparation of milligram quantities. 
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A more recent, and highly effective, third method is 
disclosed in WO 90/02749. The basic method of peptide 
synthesis disclosed therein uses a polymer substrate— 
especially a polyethylene substrate—Which is preferably in 
the form of a sheet or ?lm, and to Which polystyrene chains 
have been grafted. The polystyrene chains, Which may bear 
further substituents Which are not reactive under the condi 
tions prevailing in the synthesis, have an estimated peak 
molecular Weight (not including optional substituents) of at 
least 200,000, and at least part of the grafted polystyrene 
chains are functionaliZed With a chemical functionality 
Which facilitates the formation of an anchoring linkage 
betWeen the polystyrene moiety and an at least N-protected 
and optionally carboXyl terminal derivatiZed amino acid. 
Very high loading With synthesiZed peptide can be 
achieved With a polystyrene-grafted polymer substrate as 
disclosed in WO 90/02749, and When in the preferred form 
of a sheet or ?lm, such a polystyrene-grafted polymer 
substrate is particularly convenient for the purposes of 
parallel synthesis of multiple peptides. Thus, for example, it 
is easy to cut a sheet or ?lm into pieces of any desired siZe 
and/or shape and to transfer such pieces, if appropriate, from 
one reaction vessel to another; furthermore, a material in the 
form of a sheet or ?lm is easy to mark for identi?cation 
purposes (eg in connection With the latter mentioned trans 
fer betWeen various reaction vessels). 
Thus, When the invention disclosed in WO 90/02749 is 
employed in the conteXt of parallel and substantially simul 
taneous synthesis of a plurality of peptides, an appropriate 
plurality of essentially identical substrates of the above 
described type are provided, after Which the synthesis pro 
ceeds as folloWs: 
a) the members of the plurality of polystyrene-grafted 
polymer substrates are optionally physically segregated 
into tWo or more sets each comprising one or more 
members of the plurality; 
b) an N-protected and optionally carboXyl terminal 
derivatiZed amino acid is coupled to the functionaliZed 
polystyrene moieties of each member of the plurality 
or, Where applicable, each member of each set, the 
N-protected and optionally carboXyl terminal deriva 
tiZed amino acid employed being identical for all the 
members of the plurality or, Where applicable, all the 
members of one set, and, Where applicable, further 
being in accordance With one of the folloWing alterna 
tives: 
(i) identical for all the sets, 
(ii) When the number of said sets is greater than tWo, 
identical for at least tWo of the sets, 
(iii) different for each set, 
the functionality and the N-protected and optionally 
carboXyl terminal derivatiZed amino acid being adapted 
to each other such that the anchoring linkage formed 
can subsequently be cleaved substantially Without deg 
radation of the peptide or protein chain Which is to be 
synthesiZed; 
c) each member of the plurality or, Where applicable, each 
member of each set is treated so as to remove the 
N-protecting group from an N-protected amino or 
substituted amino group of the coupled and N-protected 
amino acid, such that reaction of the amino or substi 
tuted amino group of the coupled amino acid With a 
carboXyl group or an activated carboXyl group of a 
further N-protected amino acid is facilitated; 
d) the amino or substituted amino group of the amino acid 
last coupled to the functionaliZed polystyrene moieties 
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of each member of the plurality or, Where applicable, of 
each member of each set is reacted With a carboXyl 
group or an activated carboXyl group of a further 
N-protected amino acid, so as to form a peptide bond 
betWeen the amino or substituted amino group and the 
carboXyl group or activated carboXyl group, the further 
N-protected amino acid being identical for all the 
members of the plurality or, Where applicable, all the 
members of one set, and, Where applicable, further 
being in accordance With one of the three alternatives 
mentioned above in connection With step b); 
e) each member of the plurality or, Where applicable, each 
member of each set is optionally treated so as to remove 
the N-protecting group from an N-protected amino or 
substituted amino group of the last-coupled 
N-protected amino acid, such that reaction of the amino 
or substituted amino group of the latter amino acid With 
a carboXyl group or activated carboXyl group of a 
further N-protected amino acid is facilitated; 
f) in those cases Where step e) has been performed, steps 
d) and e) are repeated a desired number of times; 
g) each member of the plurality or, Where applicable, each 
member of each set is optionally treated so as to remove 
some or all protecting groups possibly remaining on the 
amino acid moieties of the synthesiZed peptide or 
protein chain; 
h) each member of the plurality or, Where applicable, each 
member of each set is optionally treated so as to cleave 
the linkage anchoring the synthesiZed peptide or pro 
tein chain to the functionaliZed polystyrene moieties of 
each member of the plurality or, Where applicable, of 
each member of each set; and, 
i) if appropriate, any further undesired group is removed 
from a synthesiZed peptide or protein chain. 
The methodology disclosed in WO 90/02749 is equally 
applicable to the synthesis of a single peptide or protein. In 
this case only one polystyrene-grafted polymer substrate of 
the type in question is used, and the alternatives mentioned 
under b) and f), above, do not then apply; apart from this, the 
steps in the process are entirely analogous to those recited 
above. 
It is also appropriate to mention here another document, 
viZ WO 91/13098. This document discloses solid supports 
Which are very closely related to the polystyrene-grafted 
substrates of WO 90/02749 and Which are suited for use in 
solid-phase biosystems, such as bioassays, e.g. immunoas 
says. The solid supports of WO 91/13098 differ from those 
of WO 90/02749 only in that they are functionaliZed With 
chemical functionalities from Which a peptide Which has 
been attached thereto, or a peptide Which has been synthe 
siZed thereon (eg in the manner disclosed in WO 
90/02749), Will not become detached under any normally 
applying chemical or physical conditions. 
After a number of years of eXperience in the handling and 
use of the inventions described in WO 90/02749 and WO 
91/13098, it has become apparent that although the 
substrate/support materials disclosed therein offer a number 
of signi?cant advantages in relation to the state of the knoWn 
art at the time of ?ling of the respective PCT applications, 
it Would nevertheless be advantageous to be able to improve 
the properties of the materials in certain respects. 
Thus, for example, it became clear that the occlusion, in 
the PE ?lm material, of polystyrene homopolymer during 
the grafting process led to undesirable inhomogeneity of the 
grafted material oWing to the formation of small bubbles or 
blisters in the material. Apart from the fact that it is 
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necessary to carry out a time-consuming extraction of this 
occluded homopolymer from the PS-grafted PE ?lm in order 
to obtain a material With satisfactorily reproducible chemical 
and physical behaviour in the context of applications to 
synthesis, the inhomogeneity due to the above-mentioned 
bubbles/blisters results in the optical properties (eg clarity, 
light transmission and re?ecting properties) of the 
PS-grafted PE-material being considerably poorer than 
could be desired. 
It has also been found that, for example, at high levels of 
loading of synthesiZed peptide or protein on the PS-grafted 
PE substrates of WO 90/02749, the mechanical properties of 
the material deteriorate, leading to a tendency for the mate 
rial to fragment in an uncontrolled fashion. 
Furthermore, the thermal and other properties of the 
PS-grafted PE substrates of WO 90/02749 impose limits on 
the nature of the functionalities Which can be introduced into 
the polystyrene part of the material, and on the conditions 
under Which the materials in question can be used (thus, for 
example, the PS-grafted PE material of WO 90/02749 
dissolves in solvents such as xylenes at 100° C.). The ability 
to be able to Withstand functionalisation conditions 
entailing, for example, the use of highly “aggressive” 
organic solvents (such as xylenes) and relatively high tem 
peratures Would permit functionalisation With a range of 
functionalities Which could considerably broaden the syn 
thetic applicability of the substrate material, and Would 
therefore constitute a highly desirable improvement of the 
material. 
Moreover, in continuing investigations of the applicabil 
ity of the substrates disclosed in W0 91/ 13098 (vide supra) 
for use in solid-phase biosystems, such as bioassays, e.g. 
immunoassays, it became more and more clear that the lack 
of hydrophilicity of the material imposed limits on its 
breadth of applicability in connection With, for example, 
assays of the ELISA type. It thus became apparent that a 
material of the general type in question but having signi? 
cantly improved hydrophilic properties Would have consid 
erable advantages. 
BRIEF DISCLOSURE OF THE INVENTION 
The present invention provides a material Which to a great 
extent meets the requirements discussed above. Thus, it has 
surprisingly been found that a polyole?n, notably 
polyethylene, Which has been subjected to a treatment 
leading to cross-linkage of the polyole?n (eg a treatment 
such as irradiation With high energy electrons or y radiation, 
or possibly treatment With a peroxide, eg an organic 
peroxide such as benZoyl peroxide) can lead to a material 
Which can subsequently undergo grafting With polymer, 
such as organic polymer, chains such as polystyrene chains, 
in the same manner as described in WO 90/02749, to give a 
grafted material Which, for example: 
(i) still possesses excellent mechanical and optical 
properties, 
(ii) can Withstand harsher chemical/physical conditions 
(eg higher temperatures, aggressive solvents) than the 
material of WO 90/02749, 
(iii) retains all the advantages of the material of WO 
90/02749 With respect to, e.g., peptide synthesis, and 
(iv) can be further modi?ed by functionalisation or 
derivatiZation With appropriate substituent groups so as 
to acquire a high degree of hydrophilicity While at the 
same time being compatible With synthetically relevant 
organic solvents and retaining good optical and 
mechanical properties. 
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Thus, solid supports of the present invention can, for 
example, be employed in a method completely analogous to 
that disclosed in WO 90/02749 to provide—on both an 
analytical and a preparative scale-desired peptides or pro 
teins in high yield and high purity, (eg in connection With 
studies in structure-activity relationships, investigations 
such as mapping of antigenic epitopes, determination of 
details of hormone-receptor interactions and screening for 
pharmacologically active peptidyl drugs). 
It is envisaged that the grafted cross-linked polyole?n 
substrates according to the invention, including hydrophilic 
versions thereof, comprising linker or spacer groups adapted 
to the particular chemistry in question may be valuable in the 
solid-phase synthesis of single or multiple polymer or 
biopolymer molecules other than peptides and proteins. 
Examples Would include analogues of oligopeptides, 
polypeptides, proteins, polyamides, and polyamino acids, 
e.g., depsipeptides, entothiopeptides, thiomethylene 
analogues, reduced peptide bond analogues, ketomethylene 
analogues, hydroxymethylene analogues, retro-inverso ana 
logues and peptides containing other peptide bond 
surrogates, lipopeptides, dehydro analogs, sulfated peptides, 
phosphorylated peptides, glycosylated peptides, cyclic 
peptides, peptides containing methylated (and otherWise 
alkylated) peptide bonds, peptides containing alfa,alfa 
disubstituted amino acids, peptides containing non 
proteinogenic amino acids, multiple antigen peptide systems 
(MAPS) [Tam, Proc. Natl. Acad. Sci. USA, 85, 5409 (1988) 
], peptoids [Simon et al., Proc. Natl. Acad. Sci. USA, 89, 
9376 (1992)], pyrrolinone-based peptidomimetics [Smith et 
al., J. Am. Chem. Sci. USA, 89, 114, 10672 (1992)] and 
other peptide mimetics and peptide mimics. Further 
examples Would include the synthesis of oligonucleotides, 
polynucleotides, nucleic acids (DNA, RNA) and analogues 
thereof, e.g., mono- [Stech et al., J. Am. Chem. Soc., 106, 
6077 (1984) and Conolly et al., Biochemistry, 23, 3443 
(1984)], dithiophosphates [Nielsen et al, Tetrahedron Lett., 
29, 2911 (1988)], methylphosphonates [Loscher and Engels, 
Nucleosides Nucleotides, 7, 729, (1988)], borano phos 
phates [Sood et al., J. Am. Chem. Soc., 112, 9000 (1990), 
etc. [Uhlmann and Peyman, Chem. Rev., 90, 544 (1990)], 
formacetal analogues [Matteucci, Tetrahedron Lett., 31, 
2385 (1990)], carbamate analogues [Coull et al., Tetrahe 
dron Lett., 28, 745, (1987) and Stirchak et al., J. Org. Chem., 
52, 4202 (1987)], siloxane analogues [Cormier et al., 
Nucleic Acids Res., 4583 (1988)], or dimethylenethio-, 
sulfoxido-, and sulfono-linked analogues [Huang et al., J. 
Org. Chem., 56, 3869 and Schneider and Benner 
[Tetrahedron Lett., 31, 335 (1990)], or circular oligonucle 
otides [Prakash and K001, J. Chem. Soc., Chem. Commun., 
1161 (1991)], morpholino-type backbone analogues 
[Stirchack et al., Nucleic Acids Res., 17, 6129 (1989)], 
peptide-backbone analogues [Tyaglov et al., Zh. Obshch. 
Khim., 57, 2124 (1987), Takemoto and Inaki, Polym. Mat. 
Sci. Eng., 58, 250 (1988)], including peptide nucleic acids 
(PNA) [Nielsen et al., Science, 254, 1947 (1991)]; Egholm 
et al., J. Am. Chem. Soc., 114, 1895 (1992) and J. Am. 
Chem. Soc., 114, 9677 (1992)]. Examples Would also 
include the synthesis of oligosaccharides, polysaccharides, 
sugars and analogues thereof [Danishefsky et al., Science, 
260, 1307 (1993)]. Finally, the synthesis of chimeric con 
jugates in any combination of the above-mentioned mol 
ecules can be envisaged. 
As a further aspect of the invention, the grafted cross 
linked polyole?n substrates, including hydrophilic versions, 
can be used to generate so-called libraries, e.g., synthetic 
peptide combinatorial libraries [Houghten et al., Nature 354, 
5,886,104 
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84 (1991)], Which consist of tens of millions of individual 
peptides, allowing for the rapid screening for biologically 
active peptides in various assay systems. The libraries may, 
for example, be prepared in the Way analogous to that 
recently described [Eichler and Houghten, in “Peptides 
1992”, C. H. Schneider and A. N. Eberle, eds., 1993, Escom 
Science publishers B.V., pp. 320—321] employing another 
contiguous support, namely the cotton carrier [Eichler et al., 
Pept. Res. 4, 296 (1991)]. 
In another aspect, it is envisaged that grafted cross-linked 
polyole?n substrates, including hydrophilic versions, may 
be valuable in the solid-phase synthesis of single or multiple 
nonpolymeric molecules. Examples Would include the syn 
thesis of organic molecules, eg a variety of therapeutic 
agents such as derivatives of 1,4-benZodiaZepines Ellman et 
al., J. Am. Chem. Soc. 114, 10997 (1992)]. 
In another line of approach, the present invention pertains 
to the advantageous use of grafted cross-linked polyole?n 
substrates, including hydrophilic versions, on Which pep 
tides or other molecular species have been bound or syn 
thesiZed directly, in solid-phase biochemistry [see, e.g., 
“Solid-Phase Biochemistry—Analytical and Synthetic 
Aspects”; W. H. Scouten, ed., John Wiley & Sons, NeW 
York, 1983], notably solid-phase biosystems, especially 
bioassays or solid-phase techniques Which concern, for 
example, diagnostic detection/quantitation (such as ELISA 
and related technologies) or af?nity puri?cation of peptides 
and proteins, e.g., antigens, immunogens, enZymes, 
antibodies, receptors, hormones, as Well as other 
biomolecules, including saccharides, lipids and nucleic 
acids [see, e.g., “Af?nity Chromatography—A Practical 
Approach”, P. D. G. Dean, W. S. Johnson and F. A. Middle, 
eds. IRL Press Ltd., Oxford, 1986; “Nucleic Acid 
HybridiZation—A Practical Approach”, B. D. Harnes and S. 
J. Higgins, IRL Press Ltd., Oxford, 1987]. Some recent 
solid-phase biochemistry techniques of particular interest 
include VLSIPS (a technology combining solid-phase syn 
thesis With photolithography) [Fodor et al., Science 251, 767 
(1991]) and immuno-PCR [Sano et al., Science 258, 120 
(1992)]. 
It is further envisaged that grafted cross-linked polyole?n 
substrates, including hydrophilic versions, may be valuable 
as aids in general organic chemistry, analytical chemistry, 
environmental chemistry and related areas of chemistry. 
Examples Would include polymer-bound reagents, ion 
exchangers, polymer-bound catalysts and polymer-bound 
species capable of binding metal ions (selectively), e.g., 
cryptands or croWn-ethers, chelating groups, and antibodies, 
such as monoclonal antibodies speci?c for mercury ions 
[Wylie et al., Proc. Natl. Acad. Sci. USA 89, 4104 (1992)], 
and other ions. Examples Would also include the immobi 
liZation of metal reagents [J. Chem. Soc. Perkin Trans I, 
3165 (1992)] and other reagents to simplify recovery and 
recycling. 
The cross-linking of the polyethylene prior to the grafting 
process leads to signi?cant improvement in the quality of the 
grafted specimens. 
In the grafting With styrene, the high level of grafting 
achievable on uncross-linked polyethylene specimens is 
ensured in the styrene/methanol mixture by a constant (loW) 
level of sWelling throughout the grafting process. HoWever, 
small inhomogeneities in the sWelling can be ampli?ed 
during the grafting process and lead to inhomogeneities in 
the grafting and at higher graft levels to the formation of 
large amounts of occluded polystyrene (homopolymer) and 
bubble formation. By choice of solvent, the formation of 
such inhomogeneities can only be avoided if the methanol 
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styrene mixture can be tuned to be an equally good (actually 
equally poor) solvent for all composition ratios of polyeth 
ylene and polystyrene. 
It is possible to envisage several mechanisms through 
Which the radiation induced cross-linking of the polyethyl 
ene prior to grafting can contribute to ensure the formation 
of homogeneous grafting. 
The cross-linking Will reduce (slightly; dependent on 
dose) the crystallinity of the polyethylene. The crystallites 
act in the uncross-linked material as large physical cross 
links that prevent the material from dissolving under the 
conditions of the grafting process. HoWever, crystallites do 
not sWell and act as such as inhomogeneities in the material. 
The cross-links Will reduce the equilibrium sWelling (in 
fact, measurement of equilibrium sWelling is a classic 
method to characteriZe the number of cross-links in a 
polymer netWork). Especially important in this context is the 
fact that the cross-links Will add an elastic part to the free 
energy of sWelling. This means that high degrees of sWelling 
in certain areas of the specimen become unfavourable, 
Whereas in the uncross-linked case they may act as sites of 
instabilities in the composition. 
In Was not a priori clear that the combination of these 
effects (and possibly others) almost totally suppresses the 
formation of occluded (homo)polystyrene. From a produc 
tion point of vieW, this is very important because it means 
that the relatively tedious extraction procedures needed to 
remove the occluded polymer can be avoided. 
BRIEF DESCRIPTION OF THE FIGURES 
FIG. 1. Analytical HPLC chromatograms of crude human 
gelsolin fragment 160—169, i.e. H-Gln-Arg-Leu-Phe-Gln 
Val-Lys-Gly-Arg-Arg-NH2, synthesiZed on: (A) the Boc 
BHA derivatiZed PS-grafted XLPE ?lm prepared according 
to Example 3(b) herein; (B) the Boc-BHA/PEO-?lm pre 
pared according to Example 4(d); and (C) the Boc-BHA/ 
AM-?lm prepared according to Example 4(c) herein. A 
#BONDAPAKTM C18 (Waters) reverse-phase column (5 pm, 
0.46><30 cm) Was employed; buffer A Was 5% v/v acetoni 
trile in Water containing 445 pl of TFA per liter, and buffer 
B Was 60% v/v acetonitrile in Water containing 390 pl of 
TFA per liter. The How rate Was 1.5 ml/min, and the linear 
gradient employed Was 0—100% of buffer B in 30 min. The 
eluents Were monitored spectrophotometrically at 215 nm. 
FIG. 2. Analytical HPLC chromatogram of crude human 
gelsolin fragment 160—169 synthesiZed on standard poly 
styrene beads. The HPLC conditions Were the same as 
described in connection With FIG. 1. 
FIG. 3. Scanning electron micrographs of: (A) ungrafted 
PE ?lm; and (B) 188% PS-grafted PE ?lm in accordance 
With WO 90/02749 (magni?cation 200x). The scale bar in 
the photographs represents 50 pm in both cases. 
FIG. 4. Scanning electron micrographs of (A) 168% 
PS-grafted XLPE ?lm and (B) 200% PS-grafted XLPE ?lm 
(magni?cation 200x). The distance represented by the scale 
bar is given on the photographs. It is apparent that the 
homogeneity of the ?lms in question is similar to that of the 
?lm shoWn in FIG. 3(A) (ungrafted, non-cross-linked PE 
?lm), and the ?lms shoW no sign of the presence of bubbles 
or blisters (due to occluded homopolymer) such as are 
clearly visible in FIG. 3(B). 
FIG. 5. Analytical HPLC chromatogram of H-Tyr-Asp 
Ala-Lys-Ser-Gly-Phe-Lys-Thr-Ala NH2, synthesiZed on an 
MBHA derivatiZed polystyrene-grafted cross-linked poly 
ethylene tube as described in Example 10. A Nucleosil C18 
reverse-phase column (5 pm, 0.46><25 cm) Was employed; 
5,886,104 
buffer AWas 5% v/v acetonitrile in Water containing 445 pl 
of TFA per liter, and buffer B Was 60% v/v acetonitrile in 
Water containing 390 pl of TFA per liter. The How rate Was 
1 ml/min, and the linear gradient employed Was 0—100% of 
buffer B in 30 min. The eluents Were monitored spectro 
photometrically at 215 nm. Temperature 40° C. 
DETAILED DESCRIPTION OF THE 
INVENTION 
In one aspect, the invention relates to a cross-linked 
polyole?n substrate grafted With polymer chains, at least 
part of the polymer chains of the polymer-grafted substrate 
being functionaliZed With a chemical functionality facilitat 
ing the formation of an anchoring linkage betWeen the 
polymer moiety and another chemical species. In important 
embodiments of the invention, the chemical functionality is 
a functionality facilitating the formation of an anchoring 
linkage betWeen the polymer moiety and an at least 
N-protected and optionally carboXyl terminal derivatiZed 
amino acid. 
A most important polymer With Which the cross-linked 
polyole?n is grafted is polystyrene, and hence, a most 
important embodiment of the invention is a cross-linked 
polyole?n substrate grafted With polystyrene chains, said 
polystyrene chains optionally further bearing substituents 
Which are not reactive under the conditions prevailing in 
peptide synthesis, at least part of the polystyrene chains of 
the polystyrene-grafted substrate being functionaliZed With a 
chemical functionality facilitating the formation of an 
anchoring linkage betWeen the polystyrene moiety and an at 
least N-protected and optionally carboXyl terminal deriva 
tiZed amino acid. 
In the folloWing detailed description, the embodiment 
using polystyrene as the polymer is the embodiment par 
ticularly discussed, but it Will be understood that also a large 
number of other suitable polymers can be used analogously 
to polystrene or With modi?cations Which Will be evident to 
the person skilled in the art, and With the same advantages 
as mentioned above compared to grafting of non-cross 
linked polyole?n. Thus, one can envision neW materials 
based on cross-linked polyole?n such as polyethylene or 
polypropylene, grafted With one or combinations of the 
folloWing monomers to give polymer or copolymer grafts 
Which can be functionaliZed easily With suitable chemical 
handles for use as solid phase carriers. There are tWo general 
methods for functionaliZation of the polymer material. One 
is by chemical modi?cation of the polymer backbone, the 
other is to use monomers With masked or unmasked chemi 
cal reactive functionalities. Apart from styrene and styrene 
derivatives, acrylates are considered the most interesting 
monomers. Maleic anhydride and its derivatives are inter 
esting because of the possibility of alternating copolymers 
With styrene. Vinyl acetate is interesting because of the 
broad spectrum of applications polyvinyl alcohol grafts 
possess. PVAL grafts offer the possibility of many chemical 
modi?cations. 
In the folloWing, various alternative monomers are listed; 
Wherever the monomers are hydrophilic, this is indicated 
With a #: 
Acrylic Monomers 
Acrylic Acid and Salts and Esters Thereof (#) 
The carboXylic acid group of polyacrylic acid is a 
suitable functionality for many purposes. The car 
boXylic acid can be derivatiZed by reaction With e.g. 
amines or alcohols. 
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Acrylamides (#) 
The amide groups can be partly hydrolyZed to give 
carboXylic acid. 
Acrylonitrile (#) 
Acrylonitrile can be partly hydrolyZed to give carboXy 
lic acid groups. Acrylonitrile can also be derivatiZed 
by electrophilic reactions on the cyano group. 
Methyl Methacrylate 
The ester group can be hydrolyZed to give a carboXylic 
acid or reacted With e.g. amines or alcohols to give 
amides and ester. 
Methyl methacrylate offers the possibility of an alter 
nating copolymer With styrene. 
2-HydroXyethyl Methacrylate (HEMA) (#) 
The free alcohol can directly be derivatiZed through 
e.g. an ether or ester functionality or be oXidiZed to 
either a reactive aldehyde or a carboXylic acid. 
Glycidyl Acrylate (#) 
The glycidyl (“epoxy”) functionality can be reacted 
With e.g. amines, alcohols or sul?des to give amines, 
ethers and thioethers, or the glycidyl group can be 
hydrolyZed to give a 1.2 dialcohol suitable for reac 
tion With e.g. aldehydes giving an acetal. 
EXamples of Other Hydrophilic Acrylic Monomers of 
Potential Interest (#) 
Acrylochloride, 2-hydroXyethylacrylate, 
2-hydroXypropylacrylate, methacrylic acid, N,N 
diethylacrylamide, N-methyl acrylamide, 2.3 
dihydroaXypropyl methacrylate, 
2-dimethylaminoethylmethacrylate, polyethylene 
glycol monomethacrylate and polyethylene glycol 
monomethylether monomethacrylate. 
Maleic Acid Derivates 
Maleic Anhydride 
E.g. as a copolymer With styrene to give a poly(styrene 
co-malic anhydride), Which can be functionaliZed by 
reaction With e.g. a mono-Boc diamine or a diamine, 
Which after deprotection of the Boc group Will give 
an aminofunctionaliZed polymer. Maleic anhydride 
shoWs strong tendency to alternation in copolymer 
iZation With styrene. N-alkyl or aryl-maleimides 
possesses the same potentials as monomers for copo 
lymeriZation With styrene. 
Vinyl Acetate 
Hydrolysis gives polyvinyl alcohol (PVAL), Which can 
easily be derivatiZed by reaction With e.g. acids, 
tosylates, ketone or aldehydes to give esters, ethers, 
ketals or acetals. 
Other Monomers 
4-Vinylpyridene 
The heterocyclic nucleus can be derivatiZed by e.g. 
electrophilic substitution, e.g. formylation or 
nitration, N-vinylpyrrolidon, vinylsulfone, vinylsul 
fonic acid, 4-vinylbenZyldimethylamine, polyethyl 
ene glycol, monomethacrylate, monoacrylate 
Suitable methods of cross-linking are irradiation With 
high-energy electrons or y radiation, although for some 
polyole?ns, such as polypropylene, a radical cross-linking 
process involving the use of e.g. a peroXide species Will 
often be the preferred process. 
The polyole?n substrate may be fashioned in any suitable 
form, for eXample a sheet, ?lm, bead, pellet, disc, ring, tube, 
rod, net, tray, microtiter plate, or multi-bladed stick (such as 
a multi-bladed stick in the form of an “immuno-stick”, or a 
functional equivalent thereof, as used in certain types of 
immunochemical assay procedure). In preferred embodi 
ments of the substrate of the invention, the polyole?n from 
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Which the cross-linked polyole?n is prepared is 
polyethylene, very suitably loW-density polyethylene, 
although high-density polyethylene is also believed to be 
suitable. 
One particularly useful form of the substrate of the 
invention is a sheet or ?lm. 
Polystyrene chains grafted to the cross-linked polyole?n 
may be chains of polystyrene itself or of polystyrene Which 
has been substituted to some extent With substituents Which 
are not capable of reaction under the conditions prevailing in 
the synthesis. Such substituents may suitably be, for 
example, alkyl substituents, such as methyl, ethyl, propyl or 
butyl, alkoxy substituents, such as methoxy, ethoxy, propoxy 
and butoxy, or aryloxy substituents, such as phenoxy. The 
substitution Will preferably take the form of substitution in 
the aromatic rings by one or more substituents, eg one or 
more of the above-mentioned substituents, although substi 
tution at non-aromatic carbon atoms of vinyl group origin 
may also be envisaged. 
Aparticularly interesting type of further substituent on the 
polymer chains such as polystyrene chains is a substituent 
Which is such that the polymer-grafted cross-linked poly 
ole?n substrate is thereby rendered sWellable by Water or 
aqueous media, Which is especially desirable When applying 
a substrate of the invention to an assay employing an 
aqueous medium, eg an immunoassay such as an ELISA 
assay. 
The substituents Which are such that the polymer-grafted 
cross-linked polyole?n substrate is thereby rendered 
sWellable by Water or aqueous media may, eg be selected 
from the group consisting of polyoxyethylene and oligooxy 
ethylene moieties, polyacrylamides and oligoacrylamides, 
polyamides and oligoamides, saccharides, including 
dextrans, cellulose, agarose, starch, and agar, peptides, 
amino acids, polycations, polyanions, polyisothiocyanates, 
and hydrophilic natural substances. 
As interesting examples, such substituents may suitably 
be derived from eg polyoxyethylene-containing species, 
such as 3,6,9-trioxadecanoic acid. Thus, e.g. 3,6,9-trioxa 
decanoyl groups are e.g. suited, as disclosed herein. Further 
suitable groups include substituents derived from N,N 
dimethylacrylamide, such as 2-(N,N-dimethylcarbamyl) 
ethyl groups, as exempli?ed further herein, beloW. 
In certain preferred embodiments of substrates according 
to the present invention, namely in embodiments in Which 
there is no particular requirement of hydrophilicity of the 
substrate, the grafted polystyrene chains are chains of non 
substituted polystyrene. 
As in the case of the substrates according to WO 
90/02749, it appears to be particularly advantageous that the 
polystyrene chains grafted to the cross-linked polyole?n 
substrate are of an estimated peak molecular Weight, not 
including optional substituents present on the polystyrene 
chains, of at least 200,000. Polystyrene chains ful?lling this 
condition may suitably be formed, as in WO 90/02749, by 
a substantially radical-initiated reaction (brought about, for 
example, by relatively loW-dose y irradiation) betWeen the 
cross-linked polyole?n substrate and optionally substituted 
styrene monomer present in a solution of the monomer in an 
organic solvent. 
With regard to the chain length (chain molecular Weight) 
of the grafted polystyrene chains, all indications are that this 
can be varied in the same manner as described in WO 
90/02749, i.e. by varying the composition of the solution of 
styrene (or substituted styrene) monomer Which is used for 
grafting. Thus, in this connection, for example, and by 
analogy With the results described in WO 90/02749, a 
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solution of composition 70:30 (v/v) methanol/styrene (or of 
a composition in the region thereof) seems to be very 
suitable for achieving grafting of suitably long chains of 
polystyrene to a cross-linked polyethylene substrate. 
It should be pointed out here, as is further discussed 
beloW, that grafting of polystyrene chains to the preferred 
cross-linked polyole?n, i.e. cross-linked polyethylene 
(XLPE), does not appear to result in occlusion of polysty 
rene homopolymer in the XLPE, and for this reason no 
extraction of the PS-grafted material is necessary. Thus, it is 
not possible to arrive at an estimate of the peak molecular 
Weight of the grafted chains in the manner employed in WO 
90/02749, i.e. by assuming that the length (or rather the 
distribution of chain molecular Weights) of homopolymeric 
polystyrene chains Which are not grafted to, but become 
occluded into, the PE material Will re?ect that of the grafted 
chains formed under the same conditions. 
Since no occluded homopolymer is formed in the case of 
the present substrates, and since the cross-linked polyole?n 
is insoluble in all available solvents, it is not possible to 
estimate peak molecular Weights of grafted PS chains in the 
Ways discussed in WO 90/02749. HoWever, the close rela 
tionship of the underlying polymer materials employed in 
the preferred embodiments of the present invention and of 
the invention described in WO 90/02749, and the use of the 
same approach to the grafting of PS chains onto the under 
lying material, make it reasonable to conclude that the 
distribution of grafted polystyrene chain lengths obtained 
under a given set of conditions using, for example, XLPE as 
the cross-linked polyole?n Will closely resemble that 
obtained under the same conditions using non-cross linked 
polyethylene (as in WO 90/02749). For this reason it is 
believed that chain molecular Weight criteria Which apply in 
the case of the invention disclosed in WO 90/02749 also 
apply in the case of the present invention, and that effects 
deriving from the magnitude of the estimated peak molecu 
lar Weight in the substrates of WO 90/02749 also apply in 
the present context. 
Thus, as in WO 90/02749, it may be concluded that When 
long, grafted polystyrene chains formed in the context of the 
present invention are functionaliZed, they may be 
presumed—in the same Way as discussed in WO 
90/02749—to behave, With regard to their reactivity toWards 
dissolved reagents, to a large extent as though they Were 
non-grafted (i.e. free) functionaliZed polystyrene chains in 
homogeneous solution. 
Further, as in WO 90/02749, it is preferred in the context 
of the present invention that the estimated peak molecular 
Weight of the polystyrene chains grafted to the polymer, not 
including optional substituents, is in the range of 300,000—1, 
600,000, in particular 400,000—1,400,000, preferably 600, 
000—1,200,000. A very suitable estimated peak molecular 
Weight of the polystyrene chains is 700,000—1,000,000. It is 
believed that the higher estimated peak molecular Weights of 
400,000 and above are particularly advantageous. 
The degree of polystyrene chain grafting of the cross 
linked polyole?n substrate, that is, the Weight percentage of 
polystyrene relative to the cross-linked polyole?n substrate, 
depends, of course, on the length of the polystyrene chains, 
the grafting site density and the dimensions of the substrate, 
and may vary Within Wide limits. Thus, in the case of, e.g., 
a sheet or ?lm of cross-linked polyole?n substrate of thick 
ness in the range of 25 to 100 pm, the degree of polystyrene 
chain grafting may be, e.g., from about 5 to about 800% by 
Weight, such as from about 10% to about 700%. Both very 
loW and very high degrees of polystyrene chain grafting, as 
Well as intermediate degrees of grafting, are of value in the 
context of preferred embodiments of the present invention. 
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Thus, for analytical purposes, Where it is normally desired 
to be able to synthesize peptide sequences of proteins on a 
small scale, typically microgram scale, the provision, for 
example, of a cross-linked polyole?n substrate With a rela 
tively loW degree of polystyrene chain grafting, such as, eg 
5 to 200%, or even 10 to 60% (for a sheet or ?lm of 
cross-linked polyole?n substrate of thickness in the range of 
25 to 100 pm), and preferably With a controlled, often loW 
extent of functionaliZation, ensures controlled limitation of 
the amount(s) of peptide(s) formed. 
Polystyrene-grafted XLPE sheet or ?lm of the present 
invention is particularly advantageous With respect to ana 
lytical aspects of peptide chemistry or biochemistry in that 
its excellent transparency to light, particularly visible light, 
and its homogeneity (both of Which are, as mentioned above, 
superior to those of the PS-grafted material according to WO 
90/02749), makes it ideal for use in conjunction With spec 
trophotometric techniques, eg for the monitoring (for 
example by an ELISA technique) of antigen/antibody reac 
tions Which can be monitored by a subsequent colour 
reaction and in Which the antigen may be a particular peptide 
sequence synthesiZed on and remaining anchored to the 
solid support. 
For preparative purposes, Where the attainment of the 
highest possible yield of a peptide or protein is clearly 
desirable, it is advantageous to use the highest practicable 
degree of grafting. From an overall point of vieW, the 
practical upper limit of the degree of grafting for a sheet or 
?lm of cross-linked polyole?n substrate of thickness in the 
range of 25 to 100 pm (as employed according to preferred 
embodiments) Will often be about 500—600% by Weight, 
although special applications may make it desirable to 
exceed this range, such as to a degree of grafting of about 
700%. On the other hand, the loWest degrees of grafting 
practicable Will normally not be beloW about 40% for such 
a thin sheet or ?lm. For most practical purposes, the degree 
of grafting of such a thin sheet or ?lm Will be in the range 
of about 100—600% and Will often be in the range of 
200—600% and, for preparative purposes, often preferably 
200—400% by Weight, Which seems to be a suitable range 
both from the point of vieW of the yield and ef?ciency of 
peptide syntheses performed using functionaliZed, grafted 
sheet. 
As Will be apparent from the examples illustrating the 
present invention, excellent yields of highly pure peptides 
are—as in the case of the invention disclosed in WO 
90/02749—obtainable. 
As mentioned above, the polystyrene-grafted cross-linked 
polyole?n substrate is formed by a substantially radical 
initiated reaction betWeen the substrate and optionally sub 
stituted styrene monomer present in a solution of said 
monomer in an organic solvent. For reasons discussed in 
WO 90/02749, it appears to be advantageous, from the point 
of vieW of obtaining long, substantially non-cross-linked 
polystyrene chains, to perform the grafting in a solvent in 
Which the groWing polystyrene chains are poorly sWelled or 
solvated, such as a hydroxylic organic solvent, in particular 
an alcohol. Preferred alcohols for this purpose are Cli4 
aliphatic alcohols. In practice, methanol has been found to 
be a most suitable solvent, but other alcohols may be 
suitable candidates, e.g. ethanol, propyl or isopropyl 
alcohols, or even n-butyl, iso-butyl, sec-butyl or tert-butyl 
alcohols. 
The volume percentage (% v/v) of optionally substituted 
styrene in the solution used for the grafting, such as a 
solution in a solvent Which sWells or solvates the groWing 
polystyrene chains poorly, eg a hydroxylic solvent as 
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explained above, in particular an alcohol as explained above, 
such as, e.g., methanol, has a marked in?uence on the 
molecular Weight of the grafted polystyrene chains formed, 
in that, at least up to a certain point, the chain-length 
increasing effect of the solvent is greater, the greater the 
volume percentage of the solvent in the solution. Thus, While 
the volume percentage of optionally substituted styrene in 
the solution may be Within a very broad range, such as 
betWeen 1 and 95%, this volume percentage Will normally 
be in the range of 10 to 90%, more usually 20 to 80%. Avery 
interesting range for the volume percentage of the optionally 
substituted styrene in the solution is betWeen 25 and 50%, 
and as Will appear from the examples, about 30% by volume 
has been found in practice to give supports With excellent 
properties. HoWever, it is possible that the optimum solvent 
composition in the context of the present invention may 
deviate someWhat from the value of about 30% styrene 
monomer found in connection With the grafting process in 
WO 90/02749. Thus, oWing to the fact that in order to sWell 
satisfactorily, the cross-linked amorphous phase of XLPE is 
believed to require a higher percentage of styrene than is the 
case for the PE material employed in WO 90/02749, it is 
likely that solutions containing slightly more than 30% of 
styrene monomer, eg in the range of 30—35%, may prove 
to be optimal, at least for XLPE, in the present context. 
The grafting process is very suitably performed by 
y-irradiation, and is then suitably performed at a dose rate in 
the range of from about 1 to about 100,000 Gy/hour, in 
particular about 200—5000 Gy/hour, such as about 300—1000 
Gy/hour. It is believed that the intensity of the irradiation is 
of considerable importance to the obtainment of the desir 
able con?guration With long, substantially non-cross-linked 
polystyrene chains; if the intensity is too high, the free 
radical formation Will be so high that the grafting Will tend 
to involve a greater number of shorter chains and perhaps a 
higher degree of chain cross-linking, both of Which are 
normally not desired. 
On the Whole, the optimiZation of chain length and 
grafting is achieved via the choice of reaction mixture, 
radiation dose-rate, and temperature during irradiation. 
While the above-described method involving y-irradiation 
is the presently preferred method, it is believed that 
polystyrene-grafted substrates and substrates grafted With 
other polymers may suitably be prepared using a different 
strategy involving conventional radical initiators, such as 
peroxides, for example hydrogen peroxide, benZoyl perox 
ide or diacetyl peroxide, or am compounds as the radical 
forming principles. Other radical-forming principles Which 
may be employed are, e.g., oZone and UV-radiation; another 
possibility is an electron beam (although of considerably 
loWer energy than employed, e.g., for cross-linking a poly 
ole?n substrate). The important thing is that the method used 
for the radical generation be one Which is suitable for 
relatively Well-controlled radical-initiated groWth of the 
polystyrene chains. It is believed that the conditions men 
tioned above concerning the importance of the properties of 
the solvent used also apply in connection With these free 
radical initiation principles. 
While the polymer-grafted cross-linked polyole?n sub 
strate may be in any suitable form, such as explained above, 
very interesting embodiments of the invention are such in 
Which it takes the form of a sheet or ?lm. The thickness of 
the cross-linked polyole?n substrate itself, for example an 
XLPE substrate, Which is the starting material for such a 
sheet or ?lm, may vary Within a Wide range and Will 
normally be from 10 to 10,000 pm, for most purposes 
preferably in the range 25 to 1000 pm, and typically in the 
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range 25 to 100 pm such as 25 to 75 pm. The grafting 
process leads, of course, to an increase in the total thickness. 
Thus, the thinner a sheet or ?lm, the greater Will the 
percentage increase in thickness be for a given set of grafting 
conditions. As an example, a thin grafted sheet or ?lm may 
have a thickness in the range of 25 to 200 pm. 
A sheet or ?lm has, as discussed in WO 90/02749, a 
number of advantages in the practical performance of, for 
example, peptide or protein synthesis. Thus, e.g., sheet or 
?lm may easily be cut out in suitable siZes for arranging in 
the reaction vessels used, such as any type of knoWn 
solid-phase peptide synthesis reaction vessels, including 
?asks, beakers, microbeakers, funnels, Wells, columns or 
nets. 
The ?lm or sheet support makes it possible, as also 
discussed in WO 90/02749, to devise neW practical Ways of 
handling the peptide synthesis. Thus, e. g., a number of sheet 
or ?lm pieces may be arranged on a common support and 
thus be kept together during the various stages of peptide 
synthesis, eg by being eXposed together to the various 
reagents and Washing solvents, or the pieces may be 
arranged in sets, each set being subjected to a particular 
combination of reaction media. 
This latter possibility facilitates ef?cient “compartmen 
taliZation” Whereby tWo or more peptides can be prepared in 
a parallel and substantially simultaneous manner, this has 
already been described in detail, above. One practical Way of 
handling the polymer support in the form of a sheet or ?lm 
for compartmentaliZation purposes is to cut the sheet or ?lm 
into a desired number of pieces Which are then marked 
indelibly, eg by means of graphite-based ink melted into 
the surface of some part of the sheet or ?lm. Another 
possibility is to have the various pieces present on one and 
the same large piece of sheet or ?lm and then treat the 
different areas (Which are suitably marked as described 
above) jointly or separately as the case may be. Evidently, 
one embodiment is to alloW the pieces to remain on one and 
the same ?lm as long as the treatments to be performed are 
the same, and then divide the ?lm into sub-units When the 
steps to be performed are different. 
The chemical functionality facilitating the formation of an 
anchoring linkage betWeen an at least N-protected and 
optionally derivatiZed amino acid and the functionaliZed 
polystyrene moiety is suitably a member of, or is derived 
from a member of the group comprising: 
chloro-, bromo- and iodo-substituted alkyl, 
amino-substituted alkyl, 
amino- and aryl-substituted alkyl, 
amino- and alkylaryl-substituted alkyl, 
hydroXy-substituted alkyl. 
The functionality, if derived from any of said group, may 
be a functionality With a spacer group such that a synthe 
siZed peptide or protein chain Will be cleavable from the 
polystyrene moiety substantially Without degradation of said 
chain. 
According to suitable embodiments of the invention, 
chloro-substituted alkyl is chloromethyl, amino-substituted 
alkyl is aminomethyl, amino- and alkyl-substituted aryl is 
ot-aminobenZyl (benZhydrylamino), amino- and alkylaryl 
substituted alkyl is selected from the group consisting of 
ot-amino-2-, ot-amino-3- and ot-amino-4-methylbenZyl (the 
latter also being knoWn as 4-methylbenZhydrylamino), and 
hydroXy-substituted alkyl is hydroXymethyl. 
Concerning the initial functionaliZation of the 
polystyrene-grafted cross-linked polyole?n substrate, more 
than ?fty methods have been described in connection With 
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traditional solid-phase peptide synthesis (see Barany and 
Merri?eld in The Peptides. Vol. 2, Academic Press, NeW 
York, 1979, pp. 1—284, and SteWart and Young, Solid Phase 
Peptide Synthesis 2nd Ed., Pierce Chemical Company, 
Illinois, 1984), of Which reactions for the introduction of 
chloromethyl (via a chloromethyl methyl ether/SnCl4 
reaction, aminomethyl (via a N-hydroXymethylphthalimide 
reaction; see Mitchell et al., Tetrahedron Lett., 3795, (1976)) 
and benZhydrylamine (Pietta and Marshall, J. Chem. Soc., 
650 (1970)) groups are the most Widely applied. Other 
reactive functionalities Which have been initially introduced 
include 4-methylbenZhydrylamine and 
4-methoXybenZhydrylamine. All of these established meth 
ods are in principle useful Within the conteXt of the present 
invention. Preferred embodiments Within the conteXt of the 
present invention employ aminomethyl as the initial 
functionality, in that aminomethyl is particularly advanta 
geous With respect to the incorporation of “spacer” or 
“handle” groups oWing to the reactivity of the amino group 
of the aminomethyl functionality With respect to the essen 
tially quantitative formation of amide bonds to a carboXylic 
acid group at one end of the spacer-forming reagent. A vast 
number of relevant spacer- or handle-forming bifunctional 
reagents have been described (see Barany et al., Int. J. 
Peptide Protein Res., 30, 705—739 (1987), especially 
reagents Which are reactive toWards amino groups, such as 
the amino group in the aminomethyl function, including a 
4-(haloalkyl)aryl-loWer alkanoic acid such as 
4-(bromomethyl)phenylacetic acid, a Boc-aminoacyl4 
(oXymethyl)aryl-loWer alkanoic acid such as Boc 
aminoacyl4-(oXymethyl)phenylacetic acid, N-Boc-p 
acylbenZhydrylamine such as N-Boc-p 
glutaroylbenZhydrylamine, N-Boc-4‘-loWer alkyl-p 
acylbenZhydrylamine such as N-Boc-4‘-methyl-p 
glutaroylbenZhydrylamine, N-Boc-4‘-loWer alkoXy-p 
acylbenZhydrylamine such as N-Boc-4‘-methoXy-p 
glutaroylbenZhydrylamine and 4-hydroXymethylphenoXy 
loWer alkanoic acid such as 4-hydroXymethylphenoXyacetic 
acid. 
Certain functionalities, such as benZhydrylamine, 
4-methylbenZhydrylamine and 4-methoXybenZhydrylamine 
Which may be incorporated for the purpose of cleavage of a 
synthesiZed peptide or protein chain from the solid support 
such that the C-terminal of the peptide or protein chain is in 
amide form, require no introduction of a spacer group, and 
any such functionality may advantageously be employed in 
the conteXt of the present invention. 
An alternative strategy concerning the introduction of 
spacer or handle groups is the so-called “pre-formed handle” 
strategy (see Tam et al., Synthesis, 955—57, (1979)), Which 
offers complete control over coupling of the ?rst amino acid, 
and eXcludes the possibility of complications arising from 
the presence of undesired functional groups not related to 
the peptide or protein synthesis. 
In this strategy, spacer or handle groups, in general spacer 
or handle groups of the same types as described above, are 
reacted With the ?rst amino acid Which it is desired to anchor 
to the solid support, the amino acid being N-protected and 
optionally protected at other side chains Which are not 
relevant With respect to the building-up of the desired 
peptide or protein chain. Suitable N-protecting groups are 
Boc, normally in combination With benZyl groups for the 
protection of side chains, and Fmoc, normally in combina 
tion With t-butyl for the protection of any side chains 
(Boc=t-butyloXycarbonyl; Fmoc=9 
?uorenylmethyloXycarbonyl), although a number of other 
possibilities eXist Which are Well knoWn in conventional 
solid-phase peptide synthesis. 
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Thus, in those cases in Which a spacer or handle group is 
desirable, the ?rst amino acid to be coupled to the solid 
support can either be coupled to the free reactive end of a 
spacer group Which has been bound to the initially intro 
duced functionality, for example aminomethyl, or can be 
reacted With the spacer-forming reagent, Which in turn is 
then reacted With the initially introduced functionality. 
Following completion of the coupling of the ?rst amino 
acid Which is to be coupled, the next stage of the solid-phase 
synthesis is the systematic elaboration of the desired peptide 
or protein chain. This elaboration involves repeated 
deprotection/coupling cycles. The temporary protecting 
group, such as a Boc or Fmoc group as described above, on 
the last-coupled amino acid is quantitatively removed by a 
suitable treatment, for example by acidolysis, such as With 
tri?uoroacetic acid, in the case of Boc, or by base treatment, 
such as With piperidine, in the case of Fmoc, so as to liberate 
the N-terminal amine function of the last-coupled amino 
acid. 
The next desired N-protected amino acid is then coupled 
to the N-terminal of the last-coupled amino acid. This 
coupling of the C-terminal of an amino acid With the 
N-terminal of the last-coupled amino acid can be achieved 
in several Ways, for example by providing the incoming 
amino acid in a form With the carboxyl group activated by 
any one of several methods, including the initial formation 
of an active ester derivative, or the initial formation of an 
anhydride. Alternatively, the carboxyl group of the incoming 
amino acid may be reacted directly With the N-terminal of 
the last-coupled amino acid With the assistance of a con 
densation reagent, for example dicyclohexylcarbodiimide or 
derivatives thereof. 
FolloWing the completed assembly of the desired peptide 
or protein chain, including protecting groups, the next step 
Will normally be deprotection of the amino acid moieties of 
the peptide or protein chain and cleavage of the synthesiZed 
peptide or protein from the solid support. These processes 
can take place substantially simultaneously, thereby provid 
ing the free peptide in the desired form. Alternatively, in 
cases in Which condensation of tWo separately synthesiZed 
peptide or protein chains is to be carried out, it is possible 
by choosing a suitable spacer group at the start of the 
synthesis to cleave the desired peptide or protein chains 
from their respective solid supports, both peptide or protein 
chains still incorporating their side-chain protecting groups, 
and ?nally removing the side-chain protecting groups after, 
for example, coupling the tWo side-chain protected peptide 
or protein chains to form a longer peptide or protein chain. 
A third possibility, Which is particularly relevant for example 
in the case of analytical aspects of peptide chemistry or 
biochemist, is to remove the side-chain protecting groups 
from the synthesiZed peptide or protein chain Without cleav 
ing the anchoring linkage holding the chain to the solid 
support. This aspect is discussed further, beloW. 
It is envisaged that polystyrene-grafted cross-linked poly 
ole?n substrates analogous to those of the present invention, 
but comprising linker or spacer groups adapted to the 
particular chemistry in question, may be valuable in the 
synthesis of single or multiple biopolymer molecules other 
than peptides. One example Would be the synthesis of 
oligonucleotides, these being conceptually simple to syn 
thesiZe since only four different reaction compartments are 
normally required, one for each of the four nucleotide units 
involved (i.e. A, T, G and C for DNA fragments, or A, G,. 
C and U for RNA fragments). Such syntheses could be 
carried out in a parallel and substantially simultaneous 
fashion, in a manner analogous to that described Within the 
context of the present invention. 
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For a number of uses, eg in a number of solid phase 
bioassays, the functionality is advantageously a functional 
ity such that the anchoring linkage ensures substantially 
permanent anchoring linkage of the species attached to the 
substrate. Such a permanent attachment may, e.g., be a 
covalent binding. By the term “substantially permanent 
anchoring linkage” is meant a bond Which under the con 
ditions prevailing in the course of the various reactions and 
treatments to Which the amino acid-, peptide- or protein 
bearing substrate is exposed (e.g. further coupling of pro 
tected and/or derivatiZed amino acids or peptides, removal 
of protecting groups, Washing, exposure to body ?uids, etc.) 
during the various steps involved in applying it to a bioassay 
procedure is stable With respect to release or loss of the 
attached (coupled) species. 
Such a substantially permanent linkage may, e.g., be a 
linkage derived from an amino-substituted alkyl group, 
preferably aminomethyl. 
A substantially permanent anchoring linkage may be 
obtained by omitting a spacer group, or by using a spacer 
group Which Will ensure a substantially permanent anchor 
ing linkage. Such as spacer group may be one derived from 
the group consisting of straight and branched chain omega 
aminoalkanoic acids, preferably a spacer group derived from 
the group consisting of 6-aminohexanoic acid, 
5-aminopentanoic acid, 4-aminobutanoic acid and 
3-aminopropanoic acid. 
In the folloWing, some examples of solid phase bioassay 
uses of the polymer-grafted polyole?n substrates according 
to the invention are discussed. 
As indicated above, the polymer-grafted polyole?n sub 
strates according to the invention can suitably be used as 
supports for components in immune assays such as ELISAs 
or RLAs. In such embodiments the substrates could be used 
as, or as coatings on, a Wide variety of surfaces, such as titer 
plate Wells, beads, holloW ?bers, ?lter surfaces etc. 
One possibility is to synthesiZe the antigenic peptides 
onto the substrates according to the invention in situ 
(substantially as mentioned above and as described in 
Example 6). In this Way a coated surface suitable for 
multiple use could be prepared. The modus operandi for 
using such a surface in an assay Would be to contact the 
surface With speci?c binding ligands (eg in the form of a 
polyvalent antiserum directed against the peptide). If ligands 
bind to the surface they can be detected by adding labelled 
anti-ligands as in a traditional immune assays (of course, 
several enhancement steps comprising anti-antibodies could 
be introduced in order to increase sensitivity by obtaining a 
tree-like structure, Wherein the “root” is the coupled 
antigen). The difference from traditional immune assays 
Would be that the step of non-speci?c binding of the peptide 
to eg a Well in a titer-plate could be omitted, as the plate 
already has the peptide ?rmly bound to the surface. Thus, 
diagnostic kits containing feWer reactants than those nor 
mally encountered commercially are interesting embodi 
ments of the present invention. On the other hand, a very 
important embodiment is Where the substrate is provided 
With a functionaliZation such that a peptide or protein, or 
DNA, can be coupled to the functionaliZed grafted polymer, 
eg by a condensation reaction, eg using a carbodiimide. 
Suitable peptides to be permanently linked to such a 
surface could be pre-identi?ed epitopes of polypeptides 
Which are subject to routine screens in the medical or 
veterinarian ?eld (antigens from microorganisms such as 
pathogenic bacteria, virus, protoZoans, fungi, helminths). 
It goes Without saying that also antibodies directed to one 
epitope of an antigen can be coupled to the substrates of the 
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invention. In such a Way a “sandwich assay” can be 
prepared, Wherein 1) a sample containing the antigen is 
added, and 2) a (optionally labelled) antibody directed 
against another epitope of the same antigen is added after 
removal of unbound antigen. 
Thus, folloWing these strategies, it is possible to deter 
mine the presence of antigens as Well as antibodies directed 
against these antigens in samples from various sources. 
Another possibility is to use DNA fragments Which are 
coupled permanently, e.g. covalently, to the substrates of the 
invention (e.g. carbodiimide coupled to aminomethylated 
substrates of the invention). Such DNA fragments can be 
used in a manner analogous to the use of antigens/ 
antibodies, as the fragments can be chosen so as to hybridiZe 
With high speci?city to other nucleic acid fragments; the 
latter should have a free end to Which a neW labelled) 
hybridiZation partner is added. 
Assays using this strategy are especially suited for the 
determination of infections With microorganisms, as the 
detection of nucleic acid fragments from such infectants is 
proof of ongoing infection. Dependent on the stringency 
conditions of the hybridiZation assay as Well as the speci 
?city of the coupled DNA fragment, it is possible to either 
determine the species of e.g. an infectious agent 
(microorganism) or even, if desired, the speci?c strain. 
Instead of a hybridiZation assay as such, the substrate 
coupled DNA can bind nucleic acids to be later used in a 
PCR ampli?cation. This use of the substrates of the inven 
tion could then serve as a “?shing-hook” for complementary 
DNA fragments and the coupled DNA could optionally 
serve as the one of tWo primers used in the PCR ampli? 
cation (if an amble amount of coupled primer is present). 
It is of course also possible to use DNA analogues instead 
of DNA as the substance coupled to the substrate according 
to the invention. This choice may give a higher degree of 
freedom in the hybridiZation step. 
All of the above-sketched embodiments can also be used 
in other scenarios Where it is desired to have the one of tWo 
binding partners af?xed to a surface, e.g. on chromato 
graphic beads in a column (for affinity chromatography) and 
the like. 
Depending of the choice of the grafted polymer it is 
possible to couple substances to the substrates of the inven 
tion in a non-covalent manner. 
One Way of achieving this is to couple, to the substrates 
of the invention, substances capable of coordinating metal 
ions on the surface; an example of such an embodiment is 
NTA coupled to agarose, Where NTA is a substituted nitrilo 
triacetic acid. Such a surface is capable of being charged 
With Ni2+ ions Which can bind polyhistidinyl residues in a 
polypeptide With high af?nity. 
The folloWing examples illustrate the invention, the 
abbreviations used being as folloWs: 
LIST OF ABBREVIATIONS 
AM: 2-(N,N-dimethylcarbamyl)ethyl 
BHA: 4-benZhydrylamine 
BHT: 2,6-di(tert-butyl)-p-cresol 
Boc: tert-butyloxycarbonyl 
BrZ: 2-bromobenZyloxycarbonyl 
BZl: benZyl 
ClZ: 2-chlorobenZyloxycarbonyl 
DCC: N,N‘-dicyclohexylcarbodiimide 
DCM: dichloromethane 
DCU: N,N‘-dicyclohexylurea 
DIC: N,N‘-diisopropylcarbodiimide 
DIEA: N,N-diisopropylethylamine 
15 
25 
35 
45 
55 
65 
20 
DMF: N,N-dimethylformamide 
FABMS: Fast atom bombardment mass spectrometry 
HOBt: 1-hydroxybenZotriaZole 
HPLC: high performance liquid chromatography 
Pam: phenylacetamidomethyl 
PE: polyethylene 
PEO: 3,6,9-trioxadecanoyl 
PP: polypropylene 
PS: polystyrene 
SEC: siZe-exclusion chromatography 
SPPS: solid phase peptide synthesis 
TFA: tri?uoroacetic acid 
TFMSA: tri?uoromethanesulfonic acid 
THF: tetrahydrofuran 
Tos: tosyl (i.e. p-toluenesulfonyl) 
XLPE: cross-linked polyethylene 
The abbreviations used for the various amino acids are in 
accordance With the recommendations of the IUPAC-IUB 
Commission of Biochemical Nomenclature [J . Biol. Chem., 
247, 977—983 (1972)], and refer in all cases to 
L-con?guration amino acids. 
Unless otherWise indicated, reagents and solvents etc. 
employed in the folloWing examples are commercially avail 
able. 
The Boc-protected 3-(4-benZhydrylamine)propionic acid 
used in Example 3(b) beloW Was prepared as folloWs: 
Hydrocinnamic acid chloride Was prepared from commer 
cially available hydrocinnamic acid (Aldrich) using thionyl 
chloride. The acid chloride Was converted to the correspond 
ing amide by reaction With 25% aqueous ammonia at a 
temperature beloW 0° C., and Friedel-Crafts acylation of the 
isolated amide using benZoyl chloride and aluminium chlo 
ride in CS2 afforded the corresponding benZophenone in 
excellent yield (95%). The latter Was transformed to 3-(4 
benZhydrylamine)-propionic acid by reduction of its oxime 
using Zinc in acetic acid folloWed by hydrolysis of the amide 
functionality. The Boc-protected acid Was prepared as 
described by SteWart and Young, Solid Phase Peptide 
Synthesis, 2nd Ed., Pierce Chemical Company, 1984, pp. 63 
and 61, and Was recrystalliZed tWice from n-hexane/toluene. 
EXAMPLE 1 
Preparation of Cross-linked Polyethylene Sheet or 
Film 
Clear, loW-density polyethylene ?lm of thickness 54 pm 
(a PE ?lm of the same type as employed in Example 1 of 
WO 90/02749 for the preparation of polystyrene-grafted 
polyethylene ?lm) Were irradiated to different absorbed 
doses With high-energy electrons from an electron accelera 
tor installed at Forskningscenter Risgz) (Risgz) National 
Laboratory); the latter accelerator produces electrons of 
energy 10 MeV, Which ensures complete penetration into 
material of thickness up to about 3.5 cm (for material of 
density 1 g/cm3), but it should be made clear here that 
electrons of considerably loWer energy, e.g. of the order of 
a feW hundred keV, Will be quite adequate to ensure com 
plete penetration of a ?lm of the thickness employed in the 
present example. 
The absorbed doses (in kGy) for various samples of ?lm 
irradiated in this manner are given in Table 1 in Example 2, 
beloW. 
Apart from a faint yelloWish colouration (characteristic of 
irradiated polyethylene), the irradiated ?lm samples (XLPE 
?lm) are visually and dimensionally indistinguishable from 
the unirradiated PE ?lm. 
EXAMPLE 2 
Preparation of Polystyrene-grafted Cross-linked 
Polyethylene Film 
Sheets of XLPE ?lm prepared as described in Example 1 
(vide supra) Were immersed in a 30% (v/v) solution of 
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styrene in methanol (both of the latter being of at least good 
reagent grade) in an aluminium container equipped With a 
lid. The container and contents Were then irradiated in a °°Co 
gamma-irradiation facility. The dose rate Was approximately 
1.2 kGy/hour, and the total absorbed dose Was 5.8 kGy. 
After irradiation, the ?lm Was removed from the 
container, rinsed/Washed With toluene and alloWed to dry in 
the air. 
Asurprising and very advantageous feature of PS-grafted 
XLPE ?lm prepared in the above manner is that the ?lm 
contains no detectable quantity of occluded polystyrene 
homopolymer, and the grafted ?lm therefore requires no 
special treatment after grafting to remove such homopoly 
mer. This is in marked contrast to the PS-grafted PE ?lm 
prepared according to WO 90/02749, Which requires pro 
longed extraction (at least about 30 hours) in a Soxhlet 
apparatus With a solvent such as dichloromethane in order to 
ensure satisfactory removal of occluded homopolymer. 
With respect to homogeneity, the PS-grafted XLPE ?lm 
shoWs no signs of the presence of the small bubbles or 
blisters Which have been found to be present in PS-grafted 
PE ?lm prepared according to WO 90/02749, and Which are 
believed to be attributable to the occlusion of polystyrene 
homopolymer Within the PS-grafted PE ?lm during the 
grafting process (see FIGS. 3 and 4). As a result, the light 
transmission and re?ection properties of PS-grafted XLPE 
?lm are far better than those of PS-grafted PE ?lm, and 
resemble those of ungrafted PE ?lm. 
The grafting results for the various samples of XLPE ?lm 
are shoWn beloW in Table 1, together With the result obtained 
using a sample of PE ?lm Which had not been subjected to 
cross-linking treatment (i.e. a sample of PE ?lm identical to 
that used as starting material in Example 1, above). 
As can be seen from the table, the percentage of grafting 
on the XLPE ?lm samples varies very little from sample to 
sample (ranging from 230 to 260%) and is only moderately 
loWer than for the PE ?lm. Since the irradiation conditions 
for the XLPE and PE ?lm Were identical, it thus appears that 
the polystyrene chains grafted to the tWo types of ?lm are of 
comparable length. 
TABLE 1 
Grafting of XLPE sheets in methanolfstyrene 70130 vfv 
Radiation dose used for % Polystyrene grafted to 
cross-linking of PE ?lm§ (kGy) the XLPE ?lm" 
O 336 
51 260 
97 250 
148 234 
195 230 
248 249 
296 249 
§Dose for incipient gel formation in this type of PE is 50 kGy. (The polyole?n 
material is per de?nition cross-linked When the dose is the dose for incipient 
gel formation or higher) 
*Graft % = [(mass of ?nal ?lm) — (mass of XLPE)] x 100/(mass of XLPE). 
Grafting performed using °°Co gamma irradiation, dose 5.8 kGy. 
EXAMPLE 3 
FunctionaliZation/activation of PS-grafted XLPE 
Film 
(a) Preparation of Aminomethylated Film 
14 g of a 168% PS-grafted XLPE ?lm [prepared as 
described in Example 2 from XLPE ?lm (electron irradia 
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tion dose 296 kGy) but using a loWer y radiation dose] Was 
cut into eight essentially identical rectangular pieces Which 
Were then placed in a 300 ml SPPS reaction vessel on a 
manual SPPS shaker and Washed With 200 ml of TFA/ 
CHZCl2 (1:1 v/v) for 10 min. Asolution of 1.0 g (5.46 mmol) 
N-(hydroxymethyl)phthalimide (97% purity; EGA 
CHEMIE) in 200 ml of TFA/CHZCl2 (1:1 v/v) Was added to 
the Washed pieces of ?lm, and the “mixture” Was shaken for 
10 min. 50 ml of TFMSA/TFA/CHZCl2 (11:18.5:18.5 v/v/v) 
Was added sloWly (ca. 2.5 ml portions) over a 6 hour period 
and shaking Was continued for another 18 hours. The pieces 
of ?lm Were isolated by ?ltration and Washed sequentially 
With the folloWing: CHZCl2 (200 ml, 4x 15 min), methanol 
(200 ml, 1><15 min), and ethanol (200 ml, 1><15 min). They 
Were then shaken in a solution of 200 ml of ethanol and 30 
ml of hydraZine hydrate for 22 hours at 60° C., the heating 
being achieved by means of a ?exible electric heating belt 
Wrapped around the reaction vessel. The sheets Were ?ltered 
from the hot mixture and Washed sequentially With the 
folloWing: hot ethanol (200 ml, 60° C., 3><20 min), hot DMF 
(200 ml, 60° C., 2><20 min), hot methanol (200 ml, 50° C., 
2><10 min), methanol (200 ml, 1><10 min), and CHZCl2 (200 
ml, 3><15 min). Finally, the sheets Were treated (neutraliZed) 
With 200 ml of DIEA/CHZCl2 (1:9 v/v) for 2><10 min, 
Washed With CHZCl2 (200 ml, 4><10 min), and dried at room 
temperature. A total of six quantitative Kaiser ninhydrin 
tests [Sarin et al., Anal. Biochem., 117, 147 (1981)] indi 
cated a degree of substitution (aminomethylation) of 
0371009 mmol of NH2 groups per gram of ?lm. 
Aminomethylation of a 200% PS-grafted XLPE ?lm 
(prepared as in Example 2 but using a slightly higher y 
radiation dose than for the 168% PS-grafted XLPE ?lm) Was 
carried out analogously to give a ?lm With a degree of 
substitution of 0841013 mmol NH2 per g. 
(b) Preparation of Boc-protected 4-benZhydrylamine 
derivatiZed Film 
Boc-protected 3-(4-benZhydrylamine)propionic acid Was 
coupled as the HOBt ester to the 0.37 mmol NHZ/g ami 
nomethylated PS-grafted XLPE ?lm prepared as in Example 
3(a), above, using the folloWing procedure: 
2.7 g of the aminomethylated ?lm Was pre-Washed in 70 
ml of DMF/CHZCl2 (1:2 v/v) for 3x3 min in a 100 ml 
reaction vessel on a manual SPPS shaker. 2.49 g (7 mmol) 
of Boc-protected 3-(4-benZhydrylamine)propionic acid and 
1.07 g (7 mmol) of HOBt Were dissolved in 50 ml of 
DMF/CHZCl2 (1:1 v/v), and the solution Was stirred in a 
screW-capped tube for 3 min at 0° C. Asolution of 1.1 ml of 
DIC in 20 ml of CHZCl2 Was added, and the mixture Was 
then stirred for 25 min at 0° C. and added to the pre-Washed 
aminomethylated ?lm. After shaking the resulting “mixture” 
for 3 hours, the ?lm Was isolated by ?ltration, Washed With 
CH2Cl2, neutraliZed With DIEA/CHZCl2 (5:95 v/v), Washed 
With CHZCl2 and dried in vacuo. Quantitative Kaiser nin 
hydrin tests (vide supra) indicated that ca. 0.08 mmol of the 
initial 0.37 mmol of amino groups per gram of ?lm had not 
coupled to the Boc-protected BHA reagent. These remaining 
free amino groups Were acetylated (“capped”) using acetic 
anhydride/pyridine/CHZCl2 (1: 1:2 v/v/v), leaving only 0.006 
mmol of uncapped, free amino groups per gram (as deter 
mined by quantitative Kaiser ninhydrin testing). 
A piece of the ?lm Was deprotected by treatment With 
TFA/CHZCl2 (1:1 v/v) for 2x1 min and 1><30 min, and 
subsequent quantitative Kaiser ninhydrin testing of the 
deprotected ?lm indicated Boc-protected BHA derivatiZa 
tion of ca. 0.27 mmol of amino groups per gram of ?lm, 
Which agrees Well With the expected value of ca. 0.28 
mmol/ g (it should be noted that because of the gain in Weight 
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of the ?lm When ca. 0.3 mmol of BHA derivative per gram 
is coupled to the aminomethylated ?lm, the calculated 
theoretical degree of substitution, i.e. mmol BHA/g of 
derivatiZed ?lm, decreases to ca. 93% of the initial value for 
mmol NHZ/g of aminomethylated ?lm. 
For unknown reasons, attempts to derivatiZe the aminom 
ethylated ?lm directly using Boc-protected 3-(4 
benZhydrylamine)propionic acid (instead of the HOBt ester 
thereof) and 0.1M DIC in CHZCl2 resulted in only ca. 50% 
substitution/derivatiZation. 
(c) Preparation of Boc-Tyr(BrZ)-Pam-?lm 
Boc-Tyr(BrZ)-4-(oxymethyl)phenylacetic acid [prepared 
by the procedure of Tam et al., Synthesis (1979) 955—57] 
Was coupled as the HOBt ester to the 0.84 mmol NHZ/g 
aminomethylated PS-grafted XLPE ?lm prepared as in 
Example 3(a), above, using the folloWing procedure: 
0.62 g of the aminomethylated ?lm Was pre-Washed in 20 
ml of DMF/CHZCl2 (1:2 v/v) for 3x3 min in a 25 ml reaction 
vessel on a manual SPPS shaker. 1.86 g (2.8 mmol) of 
Boc-Tyr(BrZ)4-(oxymethyl)phenylacetic acid, 429 mg (2.8 
mmol) of HOBt and 576 mg (2.8 mmol) of DCC Were 
dissolved in 21 ml of DMF/CHZCl2 (1:1 v/v), and the 
solution Was stirred for 1 hour, ?ltered and added to the 
preWashed aminomethylated ?lm. After shaking the result 
ing “mixture” overnight, the ?lm Was isolated by ?ltration, 
Washed With CH2Cl2, neutraliZed With DIEA/CHZCl2 (5:95 
v/v), Washed With CHZCl2 and dried in vacuo. Quantitative 
Kaiser ninhydrin tests (vide supra) indicated that ca. 0.008 
mmol of the initial 0.84 mmol of amino groups per gram of 
?lm had not coupled to the Boc-protected reagent. These 
remaining free amino groups Were acetylated as in Example 
3(b), above, leaving only 0.004 mmol of uncapped, free 
amino groups per gram (as determined by quantitative 
Kaiser ninhydrin testing). 
A piece of the ?lm Was deprotected as in Example 3(b), 
and subsequent quantitative Kaiser ninhydrin testing of the 
deprotected ?lm indicated Boc-Tyr(BrZ)-Pam- substitution 
of ca. 0.57 mmol of amino groups per gram of ?lm, Which 
agrees Well With the expected value. 
As in Example 3(b), and for unknoWn reasons, attempts to 
derivatiZe the aminomethylated ?lm directly using Boc-Tyr 
(BrZ)-4-(oxymethyl)-phenylacetic acid (instead of the 
HOBt ester thereof) and DCC resulted in only ca. 20% 
substitution. 
EXAMPLE 4 
Preparation of Hydrophilic Films 
(a) Preparation of High-level Aminomethylated 
PS-grafted XLPE Film 
A piece (2.8317 g, ca. 17.1 mmol) of 168% PS-grafted 
XLPE ?lm as employed in Example 3(a), above, Was 
Washed tWice With CHZCl2 and then shaken for 10 min in a 
solution of 3.1769 g (17.9 mmol) of N-(hydroxymethyl) 
phthalimide in 200 ml of TFA/CHZCl2 (1:3 v/v). TWo 1.0 ml 
portions of TFMSA Were then added With an interval of one 
hour, and the “mixture” Was then shaken sloWly overnight. 
The light yelloW ?lm Was Washed three times With CHZCl2 
and tWice With chloroform. Elementary analysis at this stage 
indicated the nitrogen content of the ?lm to be 4.11%, 
corresponding to 91.5% substitution of the aromatic rings of 
the polystyrene part of the ?lm. This intermediate ?lm 
sWells in CH2Cl2, DMF and chloroform. When dry, or in 
solvents With little or no sWelling ability, the ?lm becomes 
rigid and fragile. For this reason the intermediate ?lm is 
suitably stored in CHZCl2 if there is to be a delay before 
completing the aminomethylation procedure. 
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To a sample of this intermediate ?lm (corresponding to 
1.383 g of the 168% PS-grafted XLPE ?lm used as starting 
material) Was added 200 ml of a 10% v/v solution of 
hydraZine hydrate in ethanol, and the “mixture” Was alloWed 
to stand Without shaking at 50° C. for six hours and then 
shaken overnight The sWelled sample Were Washed tWice 
With hot ethanol, thrice With chloroform, thrice With CHZCl2 
and six times With DMF/CH2Cl2. 
The product, i.e. high-level aminomethylated ?lm, may be 
stored in CH2Cl2; hoWever, on prolonged storage for more 
than about 3 Weeks at room temperature it becomes rigid. 
(b) Preparation of Boc-protected 4-benZhydrylamine 
derivatiZed High-level Aminomethylated Film 
This Was performed using a procedure analogous to that 
described in Example 3(b) (vide supra), but starting from the 
product sample prepared according to Example 4(a), 
together With 1.0 mmol of Boc-protected 3-(4 
benZhydrylamine)propionic acid and the corresponding 
amount of DIC. The resulting ?lm Was subjected to a 
“standard Washing procedure” (referred to as such elseWhere 
herein) involving shaking the ?lm tWice in DMF, tWice in 
CH2Cl2, tWice in DIEA/CHZCl2 (5:95 v/v) and then four 
times in CH2Cl2. 
(c) Preparation of 2-(N,N-dimethylcarbamyl)ethyl 
modi?ed, Boc-protected 4-benZhydrylamine-derivatiZed 
Film 
Aportion of product ?lm prepared according to Example 
4(b) above (equivalent to 0.898 g of 168% PS-grafted XLPE 
?lm) Was shaken overnight at 50°—55° C. With 200 ml of a 
10% W/v solution of N,N-dimethylacrylamide in DMF con 
taining 1 mg of BHT. The ?lm Was then subjected to the 
standard Washing procedure described in Example 4(b), 
above. 
Quantitative Kaiser ninhydrin testing indicated that 0.076 
mmol of NH2 groups per gram of ?lm remained unsubsti 
tuted. The ?lm Was acetylated as described in Example 3(b), 
subjected to the standard Washing procedure, subjected to 
further acetylation for 2 hours using 0.5M acetylimidaZole 
in CH2Cl2, and ?nally Washed by the standard Washing 
procedure. Quantitative Kaiser ninhydrin testing indicated 
that only 0.0061 mmol of NH2 groups per gram of ?lm then 
remained unsubstituted. 
The resulting ?lm (Which for convenience is denoted 
Boc-BHA/AM-?lm) is highly transparent and uniform in 
appearance. It sWells in solvents such as, e.g., CH2Cl2, 
DMF, ethanol and—particularly interestingly—in Water. 
When dried (i.e. free of solvents capable of sWelling the 
?lm) the ?lm is fragile, Whereas the sWollen ?lm is soft and 
pliable. The sWollen hydrophilic ?lm is someWhat less 
resistant to tearing than the non-hydrophilic ?lm. 
The content of BHA groups in Boc-BHA/AM-?lm pre 
pared in the above manner Was determined by quantitative 
Kaiser ninhydrin tests after deprotecting the BHA groups 
using TFA/CHZCl2 (1:1 v/v). The results indicated 
011610.014 mmol of BHA amino groups per gram of ?lm. 
(d) Preparation of 3,6,9-trioxadecanoyl-modi?ed, Boc 
protected 4-benZhydrylamine-derivatiZed Film 
Aportion of product ?lm prepared according to Example 
4(b) above (equivalent to 0.485 g of 168% PS-grafted XLPE 
?lm) Was subjected to the standard Washing procedure. It 
Was then shaken for 16 hours in a solution of 3,6,9 
trioxadecanoic acid [prepared according to U. Heilmann and 
F. Vogtle, Liebigs Ann. Chem. (1980) 858—862], HOBt and 
DIC (concentration of all three reagents 0.1M) in CH2Cl2/ 
DMF (1.1 v/v). The ?lm Was subjected to the standard 
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Washing procedure, shaken again for 16 hours in 3,6,9 
trioxadecanoic acid/HOBt/DIC solution as before, and 
?nally Washed using the standard Washing procedure. 
Quantitative Kaiser ninhydrin testing indicated that only 
0.0017 mmol of NH2 groups per gram of ?lm remained 
unsubstituted, and the ?lm Was therefore not subjected to 
any further treatment to reduce the number of unsubstituted 
amino groups. 
As With the ?lm prepared according to Example 4(b), the 
resulting ?lm (Which for convenience is denoted Boc-BHA/ 
PEO-?lm) is highly transparent and uniform in appearance, 
and it sWells in solvents such as CH2Cl2, DMF, ethanol and 
Water. The ?lm is soft and pliable When sWollen, and is 
considerably more resistant to tearing than the AM-modi?ed 
?lm prepared according to Example 4(c). 
The content of BHA groups in Boc-BHA/PEO-?lm pre 
pared in the above manner Was determined by quantitative 
Kaiser ninhydrin tests after deprotecting the BHA groups 
using TFA/CHZCl2 (1:1 v/v). The results indicated 
010510.008 mmol of BHA amino groups per gram of ?lm. 
EXAMPLE 5 
Hygroscopicity of the Hydrophilic Films (Boc 
BHA/AM-?lm and Boc-BHA/PEO-?lm) 
Samples of the tWo types of ?lm Were dried overnight 
over PZO5 at a pressure of approximately 0.005 mmHg until 
constant Weight Was attained. Upon exposing the thus-dried 
?lms to air at 25° C. and 50% relative humidity the gain in 
Weight Was as folloWs: 
Before Weighing prior to, e.g., quantitative Kaiser ninhy 
drin tests, the ?lms Were Washed With CHZCl2 and dried at 
approximately 0.005 mmHg for at least one hour, the Weight 
of the ?lms becoming constant after ca. 30 minutes. 
EXAMPLE 6 
Peptide Synthesis 
General procedures: Standard solid-phase reaction vessels 
[Merri?eld et al. Biochemistry 21 (1982) 5020] Were 
employed for the syntheses. The quantitative Kaiser ninhy 
drin test (vide supra) Was used routinely throughout the 
syntheses to determine the extent of amino acid coupling as 
Well as deprotection. HoWever, all ninhydrin values in the 
folloWing are only indicative values, since they are not 
corrected for potential background, and since it is not knoWn 
hoW Well the normally employed extinction coef?cients can 
be applied. 
HF reactions Were carried out in a Dia?on HF apparatus 
from Toho Kasei (Osaka, Japan). A #BONDAPAKTM C18 
(Waters) reverse-phase column (5 pm, 0.46><30 cm) Was 
used for analytical HPLC of the peptides on a SP 8000 
instrument. Buffer A for the elution gradient Was 5% v/v 
acetonitrile in Water containing 445 pl of TFA per liter, and 
buffer B Was 60% v/v acetonitrile in Water containing 390 pl 
of TFAper liter. The How rate Was 1.5 ml/min, and the linear 
elution gradient employed Was 0—100% of buffer B over a 
period of 30 min. The eluents from the column Were 
monitored spectrophotometrically at 215 nm. 
The crude peptides Were puri?ed on a semi-preparative 
C18 reverse-phase column (5 pm, 1.0><25 cm), and the 
molecular Weight of the puri?ed products Was determined by 
FABMS. 
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Synthetic protocol: Unless otherWise stated, the syntheses 
Were carried out employing the folloWing double coupling 
protocol for coupling of Boc-Phe, Boc-Val, Boc-Leu, Boc 
Gly, Boc-Ser(BZl), Boc-Thr(BZl) and Boc-Lys(ClZ): 
(1) Boc-deprotection With TFA/CHZCl2 (1:1 v/v; 2><1 min 
and 1><30 min); 
(2) Washing With CHZCl2 (6><1 min); 
(3) Neutralization With DIEA/CHZCl2 (1:19 v/v; 2><2 min 
and 2x1 min); 
(4) Washing With CHZCl2 (4><1 min); 
(5) Samples of the ?lm support Were occasionally cut off 
to check the deprotection, and thereby the number of 
groWing peptide chains, by means of the quantitative 
Kaiser ninhydrin test; 
(6) In situ coupling With 0.1M Boc-amino acid and 0.1M 
DIC dissolved in CH2Cl2. The coupling reaction Was 
alloWed to proceed for a total of 2 hours (With shaking); 
(7) Washing With DMF (2><2 min) and CHZCl2 (2><2 min); 
(8) Neutralization With DIEA/CHZCl2 (1:19 v/v; 2><2 
min); 
(9) Washing With CHZCl2 (4><1 min); 
(10) Samples of the ?lm support Were occasionally cut off 
(and neutraliZed) to check completeness of the coupling 
reaction by means of the quantitative Kaiser ninhydrin 
test; 
(11) A second coupling Was performed With the amino 
acid in the form of 0.1M pre-formed symmetrical 
anhydride in 50% DMF/CHZCl2 With shaking for 2 
hours; 
(12) Repetition of steps (7)—(10); 
(13) In selected positions (Where appropriate) acetylation 
(“capping”) Was performed using acetic anhydride/ 
pyridine/CHZCl2 (1:1:2 v/v/v); 
(14) When a capping step had been performed, a quanti 
tative Kaiser ninhydrin test Was occasionally carried 
out to check the extent of substitution. 
Synthesis of H-Gln-Arg-Leu-Phe-Gln-Val-Lys-Gly 
Arg-Arg-NH2 on Film Supports and on Standard 
Polystyrene Beads 
Human gelsolin fragment 160—169, i.e. H-Gln-Arg-Leu 
Phe-Gln-Val-Lys-Gly-Arg-Arg-NH2 [designated hGS 
(160—169)], Was synthesiZed on the BHA derivatiZed forms 
of (a) the PS-grafted XLPE ?lm, (b) the hydrophilic PEO 
modi?ed PS-grafted XLPE ?lm, and (c) on the hydrophilic 
AM-modi?ed PS-grafted XLPE ?lm, as Well as on (d) a 
commercially available, BHA-derivatiZed standard polysty 
rene resin in bead form, ie a resin of the “Merri?eld” type 
(Peninsula Laboratories, San Francisco, USA). 
The synthesis employed conventional solid-phase 
chemistry, using the TFA-labile Boc group for temporary 
protection, and the HF-labile 2-chlorobenZyloxycarbonyl 
(ClZ) and tosyl (Tos) groups for “permanent” protection of 
Lys and Arg, respectively. The structure of the fully pro 
tected hGS-(160—169) is Boc-Gln-Arg(Tos)-Leu-Phe-Gln 
Val-Lys(ClZ)-Gly-Arg(Tos)-Arg(tos)-BHA-support. The 
solid-phase assembly folloWed the synthetic protocol out 
lined above, With the folloWing modi?cations: 
1) Boc-Gln Was double coupled as HOBt ester to mini 
miZe the dehydration of amide to nitrile [Mojsov et al., 
J. Org. Chem. 45 (1980) 555]; the HOBt ester Was 
formed in situ by combining equimolar (0.1M 
concentration) amounts of Boc-Gln, DCC and HOBt in 
DMF/CHZCl2 (3:7 v/v) in the reaction vessel. 
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2) For coupling of Boc-Phe163 to Gln164, both the ?rst and 
the second coupling Were With the pre-formed sym 
metrical anhydride in DMF/CHZCl2 (2:8 v/v) to mini 
miZe pyrrolidone carboxylic acid formation [DiMarchi 
et al., Int. J. Peptide Protein Res. 19 (1982) 88]. 
The fully protected hGS-(160—169) Was treated With 
TFA/CHZCl2 (1:1 v/v) to remove the N-terminal Boc group 
prior to HF cleavage. Deprotection and release of the free 
hGS-(160—169) from the ?lm supports Was accomplished 
(individually) using a 10% solution of anisole in anhydrous 
HF, With stirring at 0° C. for 60 min and then at room 
temperature for a further 30 min. The hGS-(160—169) bound 
to the beaded polystyrene resin Was deprotected and cleaved 
from the resin under conditions similar to those for ?lm 
bound hGS-(160—169); hoWever, stirring Was carried out 
only for 60 min at 0° C., Which may account for the less 
ef?cient deprotection of the Arg(Tos) residues (as judged by 
the pro?le of the HPLC chromatogram in FIG. 2). 
After removal of HF, the crude products Were stirred With 
dry diethyl ether (15 ml each, 3><3 min), ?ltered off, dried in 
air for 20 min, and then extracted into 10% aqueous acetic 
acid (15 ml each, 3><15 min). Aliquots Were analyZed by 
reverse-phase HPLC (before freeZing and lyophiliZing the 
remaining solution) to establish the purity of the peptides. 
FIGS. 1 and 2 shoW HPLC chromatograms of the unpu 
ri?ed peptides. It is apparent that the purity is good in each 
case, and in particular it can be seen that only minor peaks 
elute ahead of the target peak in the chromatogram, indi 
cating the absence of signi?cant amounts of deletion 
sequences. The crude hGS-(160—169) products Were puri 
?ed on a semi-preparative C18 HPLC column, and the 
correct molecular Weight (MW) of the puri?ed hGS 
(160—169) Was con?rmed by mass spectroscopic determi 
nation (MW found: 1285.8; MW calcd.: 1285.8). 
Speci?c details on the synthesis of hGS-(160—169) on the 
four different supports are given in the folloWing. 
(a) Synthesis on the Boc-BHA derivatiZed PS-grafted 
XLPE ?lm: The synthesis Was initiated on 2.7 g of Boc-BHA 
derivatiZed PS-grafted XLPE ?lm prepared according to 
Example 3(a) (initial substitution ca. 0.27 mmol of BHA/g) 
using a 70 ml reaction volume and a 100 ml SPPS reaction 
vessel. Boc-Lys(ClZ)163, Boc-Arg(Tos)168 and Boc-Gln169 
Were each coupled three times to obtain satisfactory 
incorporation, as judged by quantitative Kaiser ninhydrin 
tests. Capping Was carried out after coupling of residues 
number 160, 161, 162 and 163. The measured ?nal loading 
Was 0.13 mmol/g. An 82 mg sample of the peptide-carrying 
?lm Was then subjected to the deprotection and release 
treatment, giving 7.1 mg of crude peptide. 
(b) Synthesis on the Boc-BHA derivatiZed and PEO 
modi?ed PS-grafted XLPE ?lm (Boc-BHA/PEO-?lm): The 
synthesis Was initiated on 0.58 g of Boc-BHA/PEO-?lm 
prepared according to Example 4(d) (initial substitution ca. 
0.11 mmol of BHA/g) using a 16 ml reaction volume and a 
30 ml SPPS reaction vessel. Boc-Arg(Tos)160 and Boc 
Phe166 Were each coupled three times, and Boc-Arg(Tos 168 
four times, to obtain satisfactory incorporation, as judged by 
quantitative Kaiser ninhydrin tests. Capping Was carried out 
after coupling of residues number 160, 161 and 164. The 
measured ?nal loading Was 0.062 mmol/g. A 140.5 mg 
sample of the peptide-carrying ?lm Was then subjected to the 
deprotection and release treatment, giving 9.3 mg of crude 
peptide. 
c) Synthesis on the Boc-BHA derivatiZed and 
AM-modi?ed PS-grafted XLPE ?lm (Boc-BHA/AM-?lm): 
The synthesis Was initiated on 0.71 g of Boc-BHA/AM-?lm 
prepared according to Example 4(c) (initial substitution ca. 
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0.12 mmol of BHA/g) using a 16 ml reaction volume and a 
30 ml SPPS reaction vessel. Boc-Arg(Tos)16O, Boc-Val164 
and Boc-Phe166 Were each coupled three times, and Boc 
Arg(Tos)168 four times, to obtain satisfactory incorporation, 
as judged by quantitative Kaiser ninhydrin tests. Capping 
Was carried out after coupling of residues number 160, 161 
and 164. For unknoWn reasons, the measured substitution 
remained constant at about 0.12 mmol/g throughout the 
synthesis. It is, hoWever, a Well-known fact that ninhydrin 
analysis is not particularly Well suited for polyamide-based 
types of supports. A 202.7 mg sample of the peptide 
carrying ?lm Was subjected to the deprotection and release 
treatment, giving 10.5 mg of crude peptide. 
(d) Synthesis on the Boc-BHA derivatiZed standard poly 
styrene beads: The synthesis Was initiated on 1.5 g of 
p-methylbenZhydrylamine resin With a substitution of ca. 
0.70 mmol/g. A 10 ml reaction volume and a 30 ml SPPS 
reaction vessel Were employed. Boc-Arg(Tos)168 Was 
coupled four times, and Boc-Gln169 Was coupled three 
times, to obtain satisfactory incorporation, as judged by 
quantitative Kaiser ninhydrin tests. The measured ?nal load 
ing Was ca. 0.21 mmol/g. A 176.8 mg sample of the 
peptide-bearing resin Was subjected to the deprotection and 
release treatment, giving 15.9 mg of crude peptide. 
EXAMPLE 7 
Grafting of Polyethylene Tube With Polystyrene 
(a) Preparation of Cross-linked Polyethylene Tube 
A loW density polyethylene tube With internal diameter 
1.5 mm and outer diameter 2.5 mm Was rolled up into a 
bundle of approx. 40 cm in diameter and irradiated With 
high-energy electrons (10 MeV) from an electron accelera 
tor installed at the Risgz) National Laboratory. The absorbed 
dose Was 307 kGy. Apart from an increased stiffness, the 
irradiated tube is visually and dimensionally indistinguish 
able from the unirradiated polyethylene tube. 
(b) Preparation of Polystyrene-grafted Cross-linked Poly 
ethylene Tubes 
A 35% (v/v) styrene/methanol (technical grade) solution 
Was bubbled thoroughly With argon for 13 min. to remove 
oxygen. The cross-linked tube, 154.23 g, Was ?lled With the 
styrene/methanol solution and both ends Were sealed. The 
tube Was irradiated in a 60 Co gamma-irradiation facility. 
The dose rate Was approx. 1.2 kGy per hour, and the 
absorbed dose Was 5.0 kGy. After the irradiation, the tube 
Was alloWed to stand for 24 hours to take advantage of the 
“post irradiation effect”. The tube Was opened and emptied 
by applying pressuriZed air. The tube Was Washed by alloW 
ing 2.0 liter of toluene (technical grade) to run sloWly 
through the tube for 3 days folloWed by Washing With 0.5 
liter of methanol (technical grade). The tube Was dried With 
pressuriZed air for tWo days. The tube Weighed 172.16 g, 
indicating a polystyrene graft of 11.6%. 
The tube appeared slightly White on the inside and more 
stiff than the irradiated polyethylene tube. 
FunctionaliZation/activation of Polystyrene-grafted 
Tubes 
(a) Preparation of Aminomethylated Tubes 
Each end of 12.3169 g of the polystyrene-grafted poly 
ethylene tube (approx. 7.0 meter) Was mounted onto an 
addition funnel under a dry nitrogen atmosphere. The tube 
Was Washed With a solution of 40.0 ml TFA/DCM (1:1 v/v) 
and emptied. A solution of 0.1950 g 
N-hydroxymethylphthalimide (1.10 mmol) in 40.0 ml TFA/ 








